Viveon Health Acquisition Corp.: auditor change — Viveon Health Acquisition restates 2022 financials due to $250K accrued expense error

Viveon Health Acquisition Corp.

Overstatement of $250,000 in accrued costs and expenses and $250,000 in professional fees for FY 2022.
Audit committee concluded on Nov 16, 2023 that the 2022 10-K should no longer be relied upon.
Error arose from same material weakness in accounts payable and accrued expenses controls noted in March 2022.
Company will restate its 2022 annual financial statements; management discussed with independent accountant Marcum LLP.
Material weakness persisted as of Dec 31, 2022; no impact on cash or prior-year filings beyond 2022.

item 4.02

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Viveon Health Acquisition Corp. reported that prior financial statements should not be relied upon.

Action: non reliance
Auditor: Marcum LLP

Exact text from the filing

On November 16, 2023, Viveon Health Acquisition Corp.’s (the “Company”) audit committee (the “Audit Committee”) of the board of directors (the “Board”) concluded, after discussion with the Company’s management and accounting professionals, that the Company’s financial statements as of and for the fiscal year ended December 31, 2022 (the “2022 10-K”), should no longer be relied upon because of an error in such financial statements.

View on SEC.gov

Browse all auditor changes →

Source: SEC EDGAR

accession 0001493152-23-042517

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.